首页> 外文期刊>Investigative radiology >Investigation of the longitudinal relaxation rate of blood after gadobenate dimeglumine administration: sequence optimization, dynamic acquisition, and clinical impact for contrast-enhanced MR angiography of the carotid arteries.
【24h】

Investigation of the longitudinal relaxation rate of blood after gadobenate dimeglumine administration: sequence optimization, dynamic acquisition, and clinical impact for contrast-enhanced MR angiography of the carotid arteries.

机译:加达苯甲酸二聚丁二胺给药后血液的纵向舒张率的研究:序列优化,动态采集和颈动脉造影增强MR血管造影的临床影响。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVES: To optimize the image acquisition parameters for improved steady-state (SS) contrast-enhanced magnetic resonance angiography (CE-MRA) of the carotid arteries with gadobenate dimeglumine. MATERIALS AND METHODS: An inversion recovery fast low-angle shot (IR-FLASH) sequence for ultrafast determination of the longitudinal relaxation rate R1 was first optimized on phantoms and tested against a routine variable repetition time (TR) spin echo sequence used as reference standard. Different combinations of flip angle (FA, between 6 and 14 degrees) and inversion time (between 134 and 9000 milliseconds) were evaluated to achieve the best trade off between speed and accuracy. The optimized sequence was thereafter used in vivo in 5 subjects to determine the time evolution of blood R1 at 1.5 T after administration of gadobenate dimeglumine at 0.1 mmol/kg bodyweight. An optimal FA for angiographic measurement was thereafter derived from the Ernst equation based on experimental values of R1 previously determined in vivo. Finally, steady-state CE-MRA examinations were performed in 20 subjects to evaluate the improved contrast achieved after optimization of the FA for maximal blood signal enhancement. RESULTS: An ultrafast IR-FLASH sequence with a flip angle of 8 degrees and a properly defined set of inversion time values was shown to give in vitro R1 determinations that were in good agreement with those obtained using a routine, time consuming, variable-TR spin echo sequence. The use of this ultrafast IR-FLASH sequence in vivo allowed the blood signal behavior in the carotid arteries after gadobenate dimeglumine administration to be monitored. Using this sequence, the R1 decreased from 8.7+/-0.96 s(1) at 30 seconds after injection to 3.8+/-0.24 s(1) at 10 minutes after injection. Based on these data for R1, the optimal FA for SS CE-MRA was calculated to be 18 degrees for a gradient echo acquisition protocol with TR=7.5 milliseconds, when gadobenate dimeglumine is used. Significantly higher blood signal to noise ratio was achieved on SS images acquired using a three-dimensional spoiled gradient echo sequence with a FA of 18 degrees than on corresponding images acquired with a FA of 35 degrees as used typically for intravascular blood pool contrast agents (52.5+/-8.3 vs. 29.5+/-6.0; P<0.05, Mann-Whitney U test). CONCLUSION: Detailed experimental knowledge of the in vivo R1 behavior of blood after gadobenate dimeglumine injection and appropriate modification of the acquisition parameters enables improved signal intensity enhancement on steady-state CE-MRA of the carotid arteries.
机译:目的:为了优化图像采集参数,以提高用ado酸二聚丁二胺的颈动脉的稳态(SS)对比增强磁共振血管造影(CE-MRA)。材料与方法:首先对人体模型优化了用于快速确定纵向弛豫率R1的反向恢复快速低角度拍摄(IR-FLASH)序列,并针对用作参考标准的常规可变重复时间(TR)自旋回波序列进行了测试。 。评估了翻转角(FA,介于6和14度之间)和反转时间(介于134和9000毫秒之间)的不同组合,以实现速度和精度之间的最佳平衡。此后,将优化的序列用于5位受试者的体内,以测定以0.1 mmol / kg体重加达苯甲酸酯二甲双胍后1.5 T时血液R1的时间演变。此后,基于先前在体内确定的R1的实验值,从Ernst方程中得出用于血管造影测量的最佳FA。最后,在20位受试者中进行了稳态CE-MRA检查,以评估在优化FA以最大程度增强血液信号后获得的改善的对比度。结果:超快的IR-FLASH序列具有8度的翻转角和一组正确定义的反转时间值,显示出的R1体外测定值与使用常规,费时的可变TR值所获得的结果相吻合自旋回波序列。体内使用这种超快的IR-FLASH序列可以监测加达贝特二聚丁二胺给药后颈动脉中的血液信号行为。使用此序列,R1从注射后30秒的8.7 +/- 0.96 s(1)降至注射后10分钟的3.8 +/- 0.24 s(1)。基于R1的这些数据,当使用g磺酸二甲双胍时,对于TR = 7.5毫秒的梯度回波采集协议,SS CE-MRA的最佳FA计算为18度。使用18度FA的三维变质梯度回波序列采集的SS图像获得的血液信噪比明显高于通常用于血管内血池造影剂的35度FA采集的相应图像(52.5 +/- 8.3与29.5 +/- 6.0; P <0.05,Mann-Whitney U检验)。结论:详细的实验知识了解了加多贝酸二甲双胍注射后血液在体内的R1行为,并对采集参数进行了适当的修改,从而改善了颈动脉稳态CE-MRA的信号强度增强。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号